Global Life Sciences
Overview
Featured News & Insights
0016
Contacts
Services
Advising on the full scope of regulatory, compliance and enforcement, litigation and transactional matters, we can offer you a holistic legal approach that will smooth your path as you navigate industry changes, technological advances, market demands and policy hurdles.
Regions
From high-profile transactions to regulatory issues and complex litigation, we collaborate across borders and disciplines to help our clients in more than 70 countries face challenges and embrace opportunities.

All Professionals
sort


Capabilities
- Antitrust and Competition
- Capital Markets
- Commercial Litigation and Disputes
- Emerging Companies and Venture Capital
- Environmental, Health, and Safety
- Food, Drug and Medical Device
- Global Arbitration, Trade and Advocacy
- Government Strategies
- Healthcare
- IP Litigation
- M&A
- Privacy and Cybersecurity
- Private Equity
- Product Liability and Mass Torts
- Technology
- Technology and Life Sciences Transactions
Related Resources
Related Blogs
News & Insights
Sidley Represents Caidya in Strategic Combination with Simbec-OrionJune 30, 2026Sidley Represents Bio-Techne in Its US$11.3 Billion Acquisition by Merck KGaAJune 25, 2026Hong Kong Life Sciences RoundtableWednesday, June 24, 2026Sidley Advises HJ Science on Its Successful Chapter 18A Listing in Hong KongJune 23, 2026
Announcements
Announcements
Conferences
Announcements
A New Era for Agricultural Subsidies: Commerce Opens Door to Countervailing Broad Farm SubsidiesJune 18, 2026AI Collaborations – From Strategic License to Strategic AcquisitionJune 10, 2026Medtech Advisory Opinion Highlights Scrutiny of Physician Product Line Royalty ArrangementsJune 9, 2026Corporate Practice of Medicine Update: California Attorney General Examines the Friendly Professional Corporation ModelJune 3, 2026
Global Arbitration, Trade and Advocacy Update
Technology and Life Sciences Transactions
Global Life Sciences Update
Healthcare Update
DOJ’s Civil Rights Fraud Initiative Raises False Claims Act Risks for Healthcare and Life Sciences CompaniesJune 4, 2026Securities Class Actions in the Life Sciences SectorSpring 2026Congress Passes Significant Federal Pharmacy Benefit Manager Reform Impacting Pharmaceutical Market AccessApril 9, 2026FDA's Crackdown On Drug Ads Conflicts With PrecedentApril 2, 2026
Reuters
Publications
Westlaw Today
Law360
Sidley Represents Caidya in Strategic Combination with Simbec-OrionJune 30, 2026Sidley Represents Bio-Techne in Its US$11.3 Billion Acquisition by Merck KGaAJune 25, 2026Sidley Advises HJ Science on Its Successful Chapter 18A Listing in Hong KongJune 23, 2026Life Sciences Transactions Partners Lila Hope and Jennifer Raab Join Sidley, Accelerating Further Growth in Life Sciences and the Palo Alto OfficeJune 22, 2026
Announcements
Announcements
Announcements
Press Releases
Sidley Highly Ranked in Chambers USA 2026June 4, 2026Sidley Wins Seven “Firm of the Year” Recognitions at the China Business Law AwardsMay 29, 2026Sidley Wins Three Awards at the Managing IP Americas Awards 2026April 10, 2026Nineteen Sidley Lawyers Named Finalists for the Women in Business Law Americas Awards 2026April 2, 2026
Accolades
Accolades
Accolades
Accolades
AI Collaborations – From Strategic License to Strategic AcquisitionJune 15, 2026The EU AI Act’s Machinery Exemption: Does It Extend to Surgical Robotics?June 11, 2026Most-Favored-Nations Drug Pricing Policy: White House Quietly Releases Report Describing Voluntary MFN DealsMay 29, 2026FDA’s Elsa at Eleven Months: AI-Powered Operations and One-Day Inspections Signal a New Oversight ParadigmMay 20, 2026
GoodLifeSci
GoodLifeSci
GoodLifeSci
GoodLifeSci
Renewed Market Optimism @ JPM 2026January 12, 2026What's Ahead for Life Sciences Dealmaking @ JPM 2026January 12, 2026Top 10 FDA Areas We Are Watching @ JPM 2026January 12, 2026Regulatory Considerations for the Next Wave of Development-Stage Transactions @ JPM 2026January 12, 2026
Videos
Videos
Videos
Videos





































